Freakonomics Radio Daniel Kahneman left his mark on academia (and the real world) in countless ways. A group of his friends and colleagues recently gathered in Chicago to reflect on this legacy — and we were there, with microphones. SOURCES: Maya Bar-Hillel, professor emeritus of psychology at the Hebrew University of Jerusalem. Shane Frederick, professor of … Read more
American politics is trapped in a duopoly, with two all-powerful parties colluding to stifle competition. We revisit a 2018 episode to explain how the political industry works, and talk to a reformer (and former presidential candidate) who is pushing for change. SOURCES: Katherine Gehl, former president and C.E.O. of Gehl Foods. Michael Porter, professor … Read more
It’s hard to know whether the benefits of hiring a celebrity are worth the risk. We dig into one gruesome story of an endorsement gone wrong, and find a surprising result. SOURCES: John Cawley, professor of economics at Cornell University. Elizabeth (Zab) Johnson, executive director and senior fellow with the Wharton Neuroscience Initiative at … Read more
Broadway operates on a winner-take-most business model. A runaway hit like Stereophonic — which just won five Tony Awards — will create a few big winners. But even the stars of the show will have to go elsewhere to make real money. (Part two of a two-part series.) SOURCES: David Adjmi, author and playwright. … Read more
The Berlin dance mecca Berghain is known for its eight-hour line and inscrutable door policy. PJ Vogt, host of the podcast Search Engine, joins us to crack the code. It has to do with Cold War rivalries, German tax law, and one very talented bouncer. SOURCES: Lutz Leichsenring, executive board member of Clubcommission Berlin … Read more
Hit by Covid, runaway costs, and a zillion streams of competition, serious theater is in serious trouble. A new hit play called Stereophonic — the most Tony-nominated play in history — has something to say about that. We speak with the people who make it happen every night. (Part one of a two-part series.) … Read more
Every December, a British man named Tom Whitwell publishes a list of 52 things he’s learned that year. These fascinating facts reveal the spectrum of human behavior, from fraud and hypocrisy to Whitwell’s steadfast belief in progress. Should we also believe? SOURCES: Tom Whitwell, managing consultant at Magnetic. RESOURCES: “Supercentenarian and Remarkable Age … Read more
An update of our 2020 series, in which we spoke with physicians, researchers, and addicts about the root causes of the crisis — and the tension between abstinence and harm reduction. SOURCES: Gail D’Onofrio, professor and chair of emergency medicine at the Yale School of Medicine and chief of emergency services at Yale-New Haven Health. … Read more
Thanks to legal settlements with drug makers and distributors, states have plenty of money to boost prevention and treatment. Will it work? (Part two of a two-part series.) SOURCES: Keith Humphreys, professor of psychiatry and behavioral sciences at Stanford University. Stephen Loyd, chief medical officer of Cedar Recovery and chair of the Tennessee Opioid … Read more
Most epidemics flare up, do their damage, and fade away. This one has been raging for almost 30 years. To find out why, it’s time to ask some uncomfortable questions. (Part one of a two-part series.) SOURCES: David Cutler, professor of economics at Harvard University. Travis Donahoe, professor of health policy and management at … Read more